Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amino Acids. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113755462B reveals high-activity enzyme mutants for chiral beta-amino acid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1163472C details a novel one-pot resolution of racemic hydantoin for high-purity chiral amino acids, offering significant cost and supply chain advantages.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.